Literature DB >> 12555676

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation.

Andrea Jegerlehner1, Tazio Storni, Gerd Lipowsky, Markus Schmid, Paul Pumpens, Martin F Bachmann.   

Abstract

Epitope density and organization have been shown to be important factors for B cell activation in many animal model systems. However, it has been difficult to separate the role of antigen organization from the role of local antigen concentrations because highly organized antigens are usually particulate whereas non-organized antigens are more soluble. Hence, highly organized and non-organized antigens may interact with different cell types and in different locations within lymphoid organs. In order to assess the role of antigen organization in regulating B cell responses, we immunized mice with highly repetitive virus-like particles, which exhibit different epitope densities covalently attached to them. Therefore, the same particulate structure was used to present identical epitopes that differed in their degree of organization. Induction of epitope-specific IgM titers, reflecting early B cell activation, were unaffected by the degree of epitope density. Furthermore, the absence of Th cells or CD21/CD35 did not reduce the IgM response. In contrast, the degree of organization was a critical factor influencing the magnitude of the epitope-specific IgG response. Moreover, the threshold for IgG responses was shifted in the absence of CD21/CD35, resulting in the requirement for higher epitope densities to allow efficient IgG responses. Thus, IgG but not IgM responses are regulated by epitope density and B cell costimulatory thresholds.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12555676     DOI: 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  75 in total

1.  Protein dynamics and the immunological evolution of molecular recognition.

Authors:  Ralph Jimenez; Georgina Salazar; Jun Yin; Taiha Joo; Floyd E Romesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

2.  Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.

Authors:  James J Moon; Heikyung Suh; Adrienne V Li; Christian F Ockenhouse; Anjali Yadava; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-12       Impact factor: 11.205

Review 3.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 4.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

5.  Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.

Authors:  Jörg Zimmermann; Erin L Oakman; Ian F Thorpe; Xinghua Shi; Paul Abbyad; Charles L Brooks; Steven G Boxer; Floyd E Romesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

6.  Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation.

Authors:  Franziska Zabel; Antonia Fettelschoss; Monique Vogel; Pål Johansen; Thomas M Kündig; Martin F Bachmann
Journal:  Immunology       Date:  2017-01-05       Impact factor: 7.397

7.  Immune-Focusing Properties of Virus-like Particles Improve Protective IgA Responses.

Authors:  Taishi Onodera; Kana Hashi; Rajni Kant Shukla; Motohiro Miki; Reiko Takai-Todaka; Akira Fujimoto; Masayuki Kuraoka; Tatsuya Miyoshi; Kazuo Kobayashi; Hideki Hasegawa; Manabu Ato; Garnett Kelsoe; Kazuhiko Katayama; Yoshimasa Takahashi
Journal:  J Immunol       Date:  2019-11-08       Impact factor: 5.422

8.  A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response.

Authors:  Nadja Thönes; Anna Herreiner; Lysann Schädlich; Konrad Piuko; Martin Müller
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Versatile virus-like particle carrier for epitope based vaccines.

Authors:  Alain C Tissot; Regina Renhofa; Nicole Schmitz; Indulis Cielens; Edwin Meijerink; Velta Ose; Gary T Jennings; Philippe Saudan; Paul Pumpens; Martin F Bachmann
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

10.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.